Nano and biotech drugs Flashcards

(112 cards)

1
Q

Which of the following is NOT considered a form of nanomedicine?
a. Sirolimus nanocrystal
b. Paclitaxel nanoparticles
c. Spironolactone suspension
d. Doxorubicin liposomes
e. All of the above are nanomedicine

A

c. Spironolactone suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following is TRUE about Tricor?
a. It consists of drug crystals of fenofibrate of about 100 mm size
b. It is a drug with high water-solubility
c. It is a typical example of new formulation of a BCS Class I drug
d. Its bioavailability is less dependent on taking with food than original fenofibrate
e. It is prepared by lyophilization

A

d. Its bioavailability is less dependent on taking with food than original fenofibrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the following is the other name(s) of Abraxane? Choose the BEST answer.
a. Nab-paclitaxel
b. Solvent-free paclitaxel
c. Taxol
d. A and B are both correct
e. A, B and C are all correct

A

d. A and B are both correct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following refers to spherical vesicles made of phospholipid bilayers?
a. Liposomes
b. Lipid nanoparticles
c. Quantum dots
d. Micelles
e. Emulsion

A

a. Liposomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which of the following ingredients in a liposomal formulation helps to physically stabilize the
bilayer structure (i.e. to “harden” the liposome)?
a. Tocopherol
b. Hydrogenated soy phophatidylcholine
c. Span 20
d. Distearolyphophatidyl glycerol
e. Cholesterol

A

e. Cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A drug X with high Vd (volume of distribution) and short plasma t1/2 (half-life) is reformulated
as liposomal product. The Vd is substantially reduced and t1/2 prolonged. What has happened
according to what I mentioned in class?
2
a. Drug X in liposomes becomes much more quickly metabolized
b. Drug X in liposomes is getting cleared by the immune system
c. Drug X in liposomes stays in circulation much longer instead of binding to peripheral
tissues
d. Drug X in liposomes now distribute to the peripheral tissues more extensively than
before
e. Drug X in liposomes must have trapped in certain organs

A

c. Drug X in liposomes stays in circulation much longer instead of binding to peripheral
tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following is FALSE comparing Fungisome (the new liposomal formulation) with
Fungizone (free drug)?
a. Fungisome penetrates into the brain better
b. Fungisome can be used at higher dose per day than Fungizone
c. Fungisome causes more toxicity in general than Fungizone
d. Fungisome is likely more expensive
e. The drug delivered by fungisome stays in systemic circulation longer

A

c. Fungisome causes more toxicity in general than Fungizone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which of the following is NOT a common advantage of nanomedicine?
a. Allow targeted delivery if properly tagged with targeting ligands
b. No risk of flocculation and coalescence
c. May sometimes improve pharmacokinetics
d. Potentially enter inside cells for drug trafficking effect
e. Can sometimes achieve solvent- or surfactant free drug solubilization

A

b. No risk of flocculation and coalescence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which of the following excipients of a Doxil (liposome formulation of doxorubicin) allows the
liposomes to stay longer in the circulation without being eliminated by immune system?
a. mPEG -distearolyphophatidyl-glycerol
b. Soy phosphatidylcholine
c. Cholesterol
d. α-Tocopherol
e. water for injection

A

a. mPEG -distearolyphophatidyl-glycerol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following is/are TRUE about Abraxane? Please choose the BEST answer?
a. Reconstitution is achieved by injecting the diluent onto the wall of the vial and not directly to
the drug
b. Reconstitution needs to be quickly done at bedside by mixing the diluent with shaking
c. If any foaming or clumping is observed, discard the product right away
d. A and B are both correct
e. A, B and C are all correct

A

a. Reconstitution is achieved by injecting the diluent onto the wall of the vial and not directly to
the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a nanocarrier is modified with ligands such as monoclonal antibodies to increase its
specificity for a particular tissue or organ, this is known as ____________
a. Targeted delivery
b. Drug solubilization
c. Drug trafficking
d. Stealth delivery
e. Controlled drug release

A

a. Targeted delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A rDNA technology product is
a. a peptide or protein
b. a DNA
c. a RNA
d. a small molecule
e. an antisense macromolecule

A

a. a peptide or protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

According to what I said in lecture, which of the following molecules is LEAST likely to trigger
an immune response via immunoglobulins?
a. Cholesterol in cell membrane
b. Protein units of the sheath of virus
c. Polysaccharide units on the cell wall of micro-organism
d. Toxins released from bacteria
e. High molecular weight glycoproteins extracted from goat milk

A

a. Cholesterol in cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which of the following is NOT a biotechnology product?
a. Glucagon-like peptides
b. Glucagon
c. Human growth hormone
d. Aspirin
e. Calcitonin

A

d. Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which of the following is FALSE about biotechnology drug products?
a. Often “mechanism driven” targeting a specific pathway
b. May be related to pharmacogenomics
c. Easy to develop generic drugs
d. Often quite potent
e. Often considered biologics

A

c. Easy to develop generic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which of the following is/are the potential disadvantages of biotechnology products? Please
choose the BEST answer.
a. High risk of triggering immune responses
b. Highly specific therapeutic activity may not be good for some diseases
c. Limited to oral dosage forms
d. A and B are both correct
e. A, B and C are all correct

A

d. A and B are both correct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which of the following is NOT a factor that normally affects whether a recombinant DNA
product dissolves in an aqueous diluent or not?
4
a. DNAase concentration in the diluent
b. pH of the diluent
c. Ionic strength of the diluent
d. Molecular weight of the product
e. Amino acid composition of the product

A

a. DNAase concentration in the diluent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of the following peptides has LOWEST water solubility?
a. Contain 4 amino acid units
b. Contain 15% of hydrophobic amino acid and 35% of ionizable amino acid
c. Contain mostly of serine, glutamate and aspartate
d. Contain 50% of tryptophan and phenylalanine plus mostly other neutral amino acids
e. Contain 50% of tryptophan and phenylalanine plus mostly arginine and lysine

A

d. Contain 50% of tryptophan and phenylalanine plus mostly other neutral amino acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Many protein drugs may precipitate in the presence of high concentration of oppositely charged
ions. This is known as ________________
a. Salting out
b. Chelation
c. Creaming
d. Ostrich ripening
e. Ionic repulsion

A

a. Salting out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. Replacing the Fc portion of monoclonal antibody generated from mice with human Fc (i.e. to
    “humanize”) is intended to
    a. Increase specificity of the antibody
    b. Reduce undesirable immune response against the antibody
    c. Reduce the cost of production
    d. Increase the strength of binding to the antigen
    e. Improve bioavailability from the injection site
A

b. Reduce undesirable immune response against the antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When reconstituting some protein drugs such as Neupogen, which of the following is sometimes
added at high concentration to block surface binding of the drugs to the plastic surface?
a. Dextrose
b. Human albumin
c. Sodium chloride
d. Lactose
e. Tween

A

b. Human albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which of the following is true regarding Lantus insulin?
a. It is a cloudy suspension at pH 4 because the insulin forms microcystals with zinc
b. It is a clear solution at pH 4 because its arginine units are uncharged
c. It is a cloudy suspension at pH 7.4 because it forms fine microcystals with zinc
d. It is a clear solution at pH 7.4 because its arginine units are charged
e. None of the above is true

A

c. It is a cloudy suspension at pH 7.4 because it forms fine microcystals with zinc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

In the table showing the top selling biotech products, which of the following is NOT one of their
therapeutic application?
a. Anticancer
b. Immunosuppression
c. Vaccine
d. Suppression of organ transplant rejection
e. Pain killing

A

e. Pain killing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

In the COVID-19 vaccines, ionizable phospholipids are one of the main ingredients. What is
their main role?
a. Form complexes with mRNA to entrap them in the nanoparticles
b. They provide “stealth” function
c. They stabilize the lipid structure of the nanoparticles
d. They serve as antioxidant
e. They are surfactants to avoid aggregation

A

a. Form complexes with mRNA to entrap them in the nanoparticles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
If you receive a newly marketed product named Gozillakingkongmab and are not sure about its storage/handling procedures, based on general knowledge about biotech drugs, which of the following should be avoided? Choose the BEST answer. a. Vigorous shaking b. Freezing c. Refrigeration at 4 o C d. A and B should both be avoided e. A, B and C should all be avoided
d. A and B should both be avoided
26
Avadar is a high molecular weight glycoprotein (MW = 123 kDa) with some hydrophobic amino acids, a few anionic, acidic amino acid units and multiple disulphide bridges. What is the most likely response of Avadar when it is diluted in a vehicle with low pH (e.g. pH 4)? a. will become more soluble as acidic amino acid units will become charged at low pH b. will become less soluble as acidic amino acid units will lose their charges at low pH c. will become more soluble as the disulphide links will become charged at low pH d. will become less soluble as the disulphide links will lose their charges at low pH e. will remain soluble regardless of pH change because at this molecular weight, the protein should be water-soluble
b. will become less soluble as acidic amino acid units will lose their charges at low pH
27
what is nanomedicine?
small devices with 100-300 nm in diameter to treat a disease or serve as a vehicle to carry therapeutic agents for disease treatment (also for diagnosis)
28
types of nanomedicine
-nanoparticles/nanospheres - liposomes - drug nanocrystals -micelles -quantum dots
29
particles made of solid lipids, polymers, or colloids, used for drug delivery (e.g. lipid nanoparticles, polymer nanoparticles, albumin nanoparticles)
nanoparticles or nanospheres
30
spherical vesicles made of phospholipids
liposomes
31
crystalline particle w/ dimension less than 1000 nm and useful for drug delivery when the drug is insoluble in water
nanocrystals
32
clusters of amphiphilic molecules for delivery of hydrophobic drugs
micelles
33
10-50 nm semiconductor (e.g. cadmium selenide), more often used for imaging, also proposed for cancer therapy
quantum dots
34
what type of nanomedicine includes emulsions or microemulsions
quantum dots
35
nanodelivery refers to
very small vehicles to deliver hard to deliver drugs (BCS class II to IV drugs)
36
why nanomedicine?
- solubilization of poorly soluble drugs - prevent degradation of unstable drugs - favorable PK (e.g longer 1/2 life, higher AUC>> improved bioavailability) -alters tissue distribution (e.g. BBB, can be penetrated by well designed nanosystems) - unique inrxn at cellular and intracellular levels -targeted delivery
37
BCS __: immediate dissolution and absorption "plenty of both" optimal
class 1
38
BCS __: dissolution limited "limited aqueous solubility"
class 2
39
BCS __: permeation limited "too water soluble or not enough permeability"
class 3
40
BCS __: bioavailability is unpredictable " not enough solubility or permeability"
class 4
41
what type of surface area distribute well on cell membrane (e.g. quantum dots for cell imaging)
large
42
endocytosis of nanosystems may sneak large therapeutic biomolecules across cell membrane (e.g. gene therapy, therapeutic peptides)
drug trafficking
43
challenges of nanomedicine
- PK is altered. behaviours of biomaterials also change at nanoscale. patient response can be unpredictable -antibodies, interferon,etc may also be elicited when being exposed to some polymers, proteins or synthetic lipids - immune system will remove foreign particulate matters through phagocytosis - extreme large surface area of nanosystems implies vulnerability to flocculation, coalescence - GMP issue ( control of size , charge, composition, sterility) -reproducability - upscalability -regulatory issues
44
how are nanocrystals manufactured
- downsizing bigger drug crystals (e.g. homogenization,milling) - micro-precipitation from drug solution
45
how are nanocrystals stabilized
w/ surfactants or amphiphilic polymer coating
46
consequence of nanocrystals not being stabilized
aggregation and creaming
47
when nanocrystals are sold in form of suspensions they are called ___
nanosuspensions
48
phospholipid molecules are ___. each has a hydrophilic polar head and hydrophobic tails
amphiphilic
49
__ have both lipophilic and hydrophilic compartments, so they can carry and deliver both lipophilic and hydrophilic drugs, as well as biomolecules (protein, DNA, RNA)
liposomes
50
True or False: liposomes are micelles
false ( they are NOT micelles)
51
A nanomedicine with a single bilayer lipid structure and has size of around 100 nm is likely _____________________
unilamellar
52
A nanomedicine with a multiple bilayer lipid structure and has size of 100- 1000 nm is likely _____________________
multilamellar
53
Which of the following may involve hours of milling of poorly soluble drug for preparation and their products generally need stabilizers or surfactants to avoid aggregation?
nanocrystals
54
what are the advantages of nanomedicine? a. protect the loaded drug from enzymatic degradation b.improve bioavailability of some drugs c. good at improving delivery of BCS class I drug d. help solubilize oily, poorly soluble drugs e. allow targeting of certain inaccessible organs
a. protect the loaded drug from enzymatic degradation b.improve bioavailability of some drugs d. help solubilize oily, poorly soluble drugs e. allow targeting of certain inaccessible organs
55
what drug is this? - brand name: rapamune -used for preventing organ rejection - 1st marketed nanocrystal drug product (2000) - prepared using "pearl mill" technique for downsizing
sirolimus
56
what drug is this? - brand name: Tricor - used for lowering triglyceride - practically insoluble - original crystalline formulation requires food for optimal oral absorption and bioavailability Nanocrystallized of Tricor - oral bioavailability increases independent of fed or fasted state - higher adhesiveness to the gut wall - making dosing regimen simplified
fenofibrate
57
__ is used for treatment of invasive infections. - large molecule; toxic
Amp-B
58
what formulation of Amp-B is this? - severe toxicity: nephrotoxicity, non-specific delivery, infusion-related toxicity -poor BBB penetration -dose limited
free Amp-B (e.g. Funizone)
59
t/f: in immunocompromised patients, free Amp-B often ineffective
true
60
what formulation of Amp-B is this? - bind Amp-B to cholesteryl sulfate - some reduction in nephrotoxicity
lipid complexed Amp-B (e.g. Amphotec)
61
what formulation of Amp-B is this? - improved solubility - reduced non specific binding - reduces toxicity - improves PK ( long circulation time) - higher doses allowed - better brain tissue permeation
liposomal Amp-B (AmBisome)
62
cheaper and more stable liposomal Amp-B is ...
fungisome
63
Which of the following ingredients in a liposomal formulation helps increase drug binding?
distearolyphophatidyl-glycerol
64
Which of the following ingredients in a liposomal formulation is an oil soluble antioxidant that chemically protect liposomes?
a- tocopherol
65
Which of the following ingredients in a liposomal formulation helps with the liposome bilayer structure?
hydrogenated soy phosphatidylcholine
66
doxil/ caelyx are called ___ liposomes
stealth
67
why are stealth liposomes called that? where does stealth come from?
mPEG coating
68
what drug is this? - commonly used for cancer chemotherapy - accumulative toxicity ( lethal CHF) - bind everywhere in body (large volume distribution and short half life)
doxorubicin
69
doxorubicin liposomes
- lipids conjugated with mPEG (avoids removal by immune system) - stay in circulation (small volume distribution and increased circulation - significant reduction in cardiotoxicity - enhanced accumulation in tumor sites
70
what drug is this? - paciltaxel bound to human albumin - avoid solvent in formulation - reduced toxicity (e.g. weight loss, neutropenia) - better efficacy for breast cancer and lung cancer - come as lyophilized "cake" of dry powder
Abraxane
71
the reconstituted suspension of Abraxane have to be ...
milky and homogenous without visible particulates
72
t/f: discard the Abraxane if foaming or clumping occurs
false ( wait until it subsides)
73
t/f: inject sodium chloride or diluent in a small manner to the wall of the vial and not directly to the drug to ensure wetting
true
74
active chemical entities of protein, peptide, or nucleic acid structure which exhibits an immunologic or pharmacodynamic effect. also known as molecular therapeutics, large molecule drugs, macromolecules, biologics
biotechnology drugs
75
a polymer of a.a. linked by peptide bonds
peptide dipeptide (2aa) tripeptide (3aa) oligopeptide (20-50 aa)
76
consists of one or more relatively long peptide. it has more than 50 aa units and typically has a 3D structure and S-S disulfide linkages
protein
77
a protein with sugar unit attached, typically on cell surface (e.g. monoclonal antibodies)
glycoprotein
78
proteins or peptides produced from the cells (bacteria, yeast or mammalian cells) transfected with recombinant DNA
rDNA
79
glucagon (29aa) calcitonin (32aa) glucagon like peptides GnRH/ LHRH VIP secretin are examples of ...drugs
peptide
80
insulin human growth hormone (HGH) are examples of ... drugs
protein
81
erythropoietin human chorionic gonadotropin antibodies are examples of ... drugs
glycoprotein
82
__ drugs - gene therapy - DNA vaccine - still at the experimental stage
DNA
83
__ drugs - mRNA vaccine - RNAi drugs (small interfering RNA/ si RNA and microRNA/miRNA) - antisense RNA - only mRNA has gone clinical
RNA
84
t/f: bioequivalent generic products are harder to develop. - fewer generic competitors even after patent expiry ( which means it is expensive)
true
85
t/f: epogen and neulasta needs to be protected from light
true
86
t/f: most biotech drugs require administration by injection
true
87
increasing absorption rate of injection
IV>SC>IM
88
why mRNA can't cross the cell membrane?
- large MW - highly negative charged - hydrophilic - easily degraded by high temp, by enzymes that break down RNA
89
mRNA is a BCS class __ drug
III (permeation limited)
90
pfizer and moderna vaccines use ionizable lipids to bind the negatively charged mRNA. what does ionizable mean?
becomes cationic at pH=4
91
design of mRNA is similar to liposomes except it does NOT have a __it is just a solid core and are often called lipid nanoparticles (LNP)
bilayer
92
mRNA as API:
nucleoside modified mRNA encoding the viral spike glycoprotein of SARS-CoV-2
93
PEG lipid is for
staying in circulation
94
DSPC as
phospholipid for structure
95
cholesterol
stabilize the structure of lipids
96
true or false: this would be soluble - smaller MW - peptide less than 5 aa - high charge - low hydrophobicity
true
97
t/f: most rDNA products have high MW. to keep them dissolved in aqueous environment, they tend to bear hydrophilic groups and preferably some charges
true
98
cationic aa (think of CAT in LA from sam and cat)
arginine and lysine (LA)
99
anionic aa
glutamate and aspartate
100
OH group: hydrophobic or hydrophilic
hydrophilic
101
phenylalanine has an aromatic group. hydrophilic or hydrophobic
hydrophobic
102
FC region (handle of fork)
interacts with the immune cells and does not look foreign to the immune system
103
FV region ( spikes of fork)
specificity/ targets and bind to receptors
104
immunoglobulin
protein sequence capable of eliciting a targeted immune response to a antigen - 2 heavy chains + 2 light chains
105
IgA, IgE,IgM,IgD,IgG,
immunoglobulin
106
any substance capable of promoting an immune response via immunoglobulins (e.g. bacteria cell walls, toxins, immunoglobulins and proteins)
antigen
107
an immunoglobulin capable of binding to the antibody and facilitating an immune response
antibody
108
several B-lymphocytes may respond to the same antigen, each produces antibodies with slight difference (recoginize and bind to differenct epitopes
polyclonal antibodies
109
antibodies come from the same cloned B-lymphocyte - same protein structure - highly specific to a particular antigen - elicits a specific immune response
monoclonal antibodies
110
__ is a humanized monocolonal antibody. blocks a certain receptor that prevents immune system to attack the implicated cells. used for cancer immunotherapy (e.g. head and neck, melanoma,lung and cervical)
keytruda (pembrolizumab)
111
__ is the first whole human monoclonal antibody drug that blocks TNFa that triggers immune responses. it is used for autoimmune disorders (e.g. RA, crohn's disease, ulcerative colitis, psoriasis)
humira (adalimuman)
112
ozempic (semaglutide) is a __ approved for treatment of type II diabetes. adminstration is SC (as ozempic) by PO (as rebelsus) approved for weight loss * as SC injection (wegovy)
glucagon like peptide